THE SPARK CO-LAB TEAM

CELINE ROYET
PharmD
COURSE DIRECTOR, ACTUATOR SERIES
KATE ROWLANDS MARQUIS
BA (Hons)
MENTOR/FACULTY


Adam is a corporate finance executive with a range of experience advising many of Australia's leading corporations undertaking corporate and commercial transactions, both as legal advisor and in investment banking, and as a corporate consultant. 
Adam has particular expertise in corporate and commercial law, focusing on governance and risk. He also has experience in transaction structuring, management and execution.

Adam is co-founder and joint managing director of Discovery Capital Partners, Executive Chairman of Acacia Coal, and co-founder and director of SPARK Co-Lab.
 

Kate is a communications specialist with a broad range of experience across science, technology, health and innovation sectors.. She is responsible for the marketing and promotion of SPARK Co-Lab's course offerings, as well as providing mentoring and​marketing guidance to participants.
 
She spent a significant part of her career in Europe and the US. Since returning to Perth, she has worked for a number of local marketing agencies. Kate now runs her own consultancy providing communications services to a range of clients from start-ups to government, with a particular focus on helping innovators tell their stories.
  

Celine is a Doctor of Pharmacy. She has over 12 years of experience in numerous international pharmaceutical companies, including Bayer and Genzyme, where she occupied various roles in Regulatory Affairs, Quality Assurance, and Operations. Her experience also includes cell therapy and regenerative medicine, and medical devices.

Implementing robust processes and knowledge from big pharma into small start-up is now the core of her interest. She currently works at Resonance Health, a UWA spin-off, and has recently launched her own consulting company, Up Compliance.​
A/PROF PETER SANTA MARIA
MBBS PhD FRACS
MENTOR/FACULTY
DR KATH GILES
MBBS MBA
MENTOR/FACULTY

DR MICHAEL WINLO
MBBS MBA
MENTOR/FACULTY
Peter is a clinician scientist with a focus on translational medicine and commercializing medtech and biopharma.

Currently he is Associate Director of Stanford SPARK and one of the Founders and Chief of the scientific advisory board for Auration Biotech as well as Founder and Chief Medical Officer for Flo-therm, a device company created in Stanford University's Biodesign course. He acted as Principal Investigator for this device in its first trial, and consults for a number of Bay Area medical device companies.

Peter was a founder and director of SPARK Co-Lab.
 
Kath is a physician and University of Western Australia MBA alumni. Currently she is the WA investment manager for Brandon Capital Partners’ Medical Research Commercialisation Fund, and CEO of OncoRes Medical
.
She was previously an investment manager at Stoneridge Ventures, and a director of Cerulean Medical and Dimerix. 


Kath sits on Curtin University's commercialisation advisory board and was a founder and director of SPARK Co-Lab.


Mike has served as CEO of Linear Clinical Research since April 2016.  In that time WA’s only dedicated early phase clinical research unit has grown significantly, earning a national Business Services Award in 2017. Prior to Linear, Michael was based in Silicon Valley as the health lead for Palantir Technologies.

Michael holds a Bachelor of Medicine and Bachelor of Surgery from the University of Western Australia as well as an MBA from Stanford University Graduate School of Business where he also completed the Stanford Biodesign Course.

He has acted as a mentor and faculty for SPARK Co-Lab's various course offerings since 2016.